-transparent.png){kind=logo}
A variety of N-(aminoalkanoyl)-S-acylcysteamine and N,N'-bis(aminoalkanoyl)cystamine salt derivatives were synthesized. Toxicity and radioprotective activity (as the dose reduction factor DRF) were determined in vivo on mice and compared to WR 2721 and S-acetylcysteamine hydrochloride. One of the most interesting compounds of this series was N-glycyl-S-acetylcysteamine trifluoroacetate (16, I 102). Structure-activity relationships are discussed.
Related Publications
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou, and
C Lion
January 1987,
Methods in enzymology,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou, and
C Lion
April 1957,
The American journal of physiology,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou, and
C Lion
September 1955,
Archives internationales de physiologie et de biochimie,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou, and
C Lion
February 1958,
Nature,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou, and
C Lion
January 1973,
Radiobiologiia,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou, and
C Lion
October 2018,
Bioscience reports,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou, and
C Lion
October 1957,
Annales de l'Institut Pasteur,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou, and
C Lion
July 1955,
Comptes rendus des seances de la Societe de biologie et de ses filiales,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou, and
C Lion
April 1964,
Acta radiologica: therapy, physics, biology,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou, and
C Lion
June 1987,
Yao xue xue bao = Acta pharmaceutica Sinica,
